References
1. Becchetti C, Zambelli MF, Pasulo L, et al. COVID-19 in an international European liver transplant recipient cohort. Gut [Internet]. 2020 Oct 1;69(10):1832 LP – 1840. Available from: http://gut.bmj.com/content/69/10/1832.abstract
2. Fishman JA, Grossi PA. Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve. Vol. 20, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020. p. 1765–7.
3. Oran DP, Topol EJ. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review. Ann Intern Med. 2020 Sep;173[5]:362–7.
4. Alkurt G, Murt A, Aydın Z, et al. Seroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey medRxiv (2020)
5. Weitz JS, Beckett SJ, Coenen AR, et al. Modeling shield immunity to reduce COVID-19 epidemic spread. Nat Med. 2020 Jun;26[6]:849–54.
6. Rauber C, Tiwari-Heckler S, Pfeiffenberger J, et al. SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study. Transplant Proc [Internet]. 2020; Available from: https://www.sciencedirect.com/science/article/pii/S0041134520329043
7. Colmenero J, Rodríguez-Perálvarez M, Salcedo M, et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021 Jan;74[1]:148–55.
8. Webb GJ, Marjot T, Cook JA, et al. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008–16.
9. Sultan S, Altayar O, Siddique SM, et al. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020 Jul;159[1]:320-334.e27.